electroCore (ECOR) EBITDA Margin Growth (1y) (2018 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | -430.00 |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 128.00 |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | -361.00 |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 141.00 |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 102.00 |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 58.00 |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 851.00 |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | -313.00 |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 535.00 |
| 10 | electroCore | 92,394.96 | -8.79 Mn | 8.36 Mn | 142.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 142.00 |
| Dec 31, 2025 | 1,177.00 |
| Sep 30, 2025 | 726.00 |
| Jun 30, 2025 | -529.00 |
| Mar 31, 2025 | 1,383.00 |
| Dec 31, 2024 | 3,266.00 |
| Sep 30, 2024 | 5,108.00 |
| Jun 30, 2024 | 9,826.00 |
| Mar 31, 2024 | 15,220.00 |
| Dec 31, 2023 | 15,489.00 |
| Sep 30, 2023 | 18,965.00 |
| Jun 30, 2023 | 12,935.00 |
| Mar 31, 2023 | 7,098.00 |
| Dec 31, 2022 | 13,587.00 |
| Sep 30, 2022 | -1,318.00 |
| Jun 30, 2022 | 14,011.00 |
| Mar 31, 2022 | 15,328.00 |
| Dec 31, 2021 | 31,419.00 |
| Sep 30, 2021 | 14,730.00 |
| Jun 30, 2021 | 37,677.00 |
| Mar 31, 2021 | 64,488.00 |
| Dec 31, 2020 | 59,379.00 |
| Sep 30, 2020 | 117,972.00 |
| Jun 30, 2020 | 120,126.00 |
| Mar 31, 2020 | 237,742.00 |
| Dec 31, 2019 | 298,616.00 |
| Sep 30, 2019 | 738,141.00 |
| Jun 30, 2019 | 213,729.00 |
| Mar 31, 2019 | 773,787.00 |
| Dec 31, 2018 | -106,242.00 |
| Sep 30, 2018 | -686,052.00 |
| Jun 30, 2018 | 7,306.00 |